U.K. Geneticists Concerned Patent Ruling On Breast Cancer Gene Test Could Stifle Innovation

News — By on December 8, 2008 at 1:00 am

A recent ruling by the European Patent Office could make it more difficult and costly for health care providers in the United Kingdom to test for the BRCA1 genetic mutation, which can increase a woman’s risk for breast cancer, London’s

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback